FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044388571> ?p ?o ?g. }

• W3044388571 endingPage "13" @default.
• W3044388571 startingPage "1" @default.
• W3044388571 abstract "White matter degeneration and demyelination are nonnegligible pathological manifestations of Alzheimer’s disease (AD). The damage of myelin sheath consisting of oligodendrocytes is the basis of AD’s unique early lesions. Shenzhiling oral liquid (SZL) was the effective Chinese herbal compound approved by the Food and Drug Administration (FDA) for the treatment of AD in China, which plays the exact therapeutic role in clinical AD patients. However, its molecular mechanism remains unclear to date. For this purpose, an in vitro mode of streptozotocin- (STZ-) induced rat oligodendrocyte OLN-93 cell injury was established to mimic the pathological changes of myelin sheath of AD and investigate the mechanism of SZL protecting injured OLN-93 cell. The results showed that STZ can decrease cell viability and downregulate the activity of PI3K/Akt-mTOR signalling pathway and the expression of myelin sheath-related proteins (MBP, MOG, and PLP) in OLN-93 cells. Both SZL-medicated serum and donepezil (positive control) can protect cells from STZ-caused damage. SZL-medicated serum increased OLN-93 cell viability in a dose- and time-dependent manner and enhanced the activity of PI3K/Akt-mTOR signalling pathway. The inhibitor of PI3K (LY294002) inhibited the protective effect of SZL-medicated serum on the STZ-injured OLN-93 cells. Furthermore, rapamycin, the inhibitor of mTOR, inhibited the promotion of cell viability and upregulation of p-mTOR and MBP caused by SZL-medicated serum. In conclusion, our data indicate that SZL plays its therapeutic role on AD by promoting PI3K/Akt-mTOR signalling pathway of oligodendrocytes. Thus, the present study may facilitate the therapeutic research of AD." @default.
• W3044388571 created "2020-07-29" @default.
• W3044388571 creator A5018415696 @default.
• W3044388571 creator A5034373217 @default.
• W3044388571 creator A5041999576 @default.
• W3044388571 creator A5065983710 @default.
• W3044388571 creator A5074567573 @default.
• W3044388571 creator A5086328631 @default.
• W3044388571 date "2020-07-24" @default.
• W3044388571 modified "2023-10-15" @default.
• W3044388571 title "Shenzhiling Oral Liquid Protects STZ-Injured Oligodendrocyte through PI3K/Akt-mTOR Pathway" @default.
• W3044388571 cites W1528865376 @default.
• W3044388571 cites W1847510535 @default.
• W3044388571 cites W1967347247 @default.
• W3044388571 cites W1976288916 @default.
• W3044388571 cites W1978304543 @default.
• W3044388571 cites W1983878988 @default.
• W3044388571 cites W1992153265 @default.
• W3044388571 cites W1992864735 @default.
• W3044388571 cites W2003151324 @default.
• W3044388571 cites W2008904654 @default.
• W3044388571 cites W2012669528 @default.
• W3044388571 cites W2014923793 @default.
• W3044388571 cites W2018289835 @default.
• W3044388571 cites W2022092287 @default.
• W3044388571 cites W2036440521 @default.
• W3044388571 cites W2059813092 @default.
• W3044388571 cites W2064002444 @default.
• W3044388571 cites W2111357727 @default.
• W3044388571 cites W2118156048 @default.
• W3044388571 cites W2125165407 @default.
• W3044388571 cites W2206286096 @default.
• W3044388571 cites W2480988676 @default.
• W3044388571 cites W2597327812 @default.
• W3044388571 cites W2609755309 @default.
• W3044388571 cites W2616327140 @default.
• W3044388571 cites W2617366469 @default.
• W3044388571 cites W2619465759 @default.
• W3044388571 cites W2753363275 @default.
• W3044388571 cites W2789336009 @default.
• W3044388571 cites W2793500227 @default.
• W3044388571 cites W2793877399 @default.
• W3044388571 cites W2794647170 @default.
• W3044388571 cites W2891150867 @default.
• W3044388571 cites W2909823347 @default.
• W3044388571 cites W2923992900 @default.
• W3044388571 cites W2954868803 @default.
• W3044388571 cites W3024610136 @default.
• W3044388571 cites W83287639 @default.
• W3044388571 doi "https://doi.org/10.1155/2020/4527283" @default.
• W3044388571 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7396001" @default.
• W3044388571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32774416" @default.
• W3044388571 hasPublicationYear "2020" @default.
• W3044388571 type Work @default.
• W3044388571 sameAs 3044388571 @default.
• W3044388571 citedByCount "6" @default.
• W3044388571 countsByYear W30443885712021 @default.
• W3044388571 countsByYear W30443885712022 @default.
• W3044388571 countsByYear W30443885712023 @default.
• W3044388571 crossrefType "journal-article" @default.
• W3044388571 hasAuthorship W3044388571A5018415696 @default.
• W3044388571 hasAuthorship W3044388571A5034373217 @default.
• W3044388571 hasAuthorship W3044388571A5041999576 @default.
• W3044388571 hasAuthorship W3044388571A5065983710 @default.
• W3044388571 hasAuthorship W3044388571A5074567573 @default.
• W3044388571 hasAuthorship W3044388571A5086328631 @default.
• W3044388571 hasBestOaLocation W30443885711 @default.
• W3044388571 hasConcept C104317684 @default.
• W3044388571 hasConcept C127561419 @default.
• W3044388571 hasConcept C1491633281 @default.
• W3044388571 hasConcept C169760540 @default.
• W3044388571 hasConcept C185592680 @default.
• W3044388571 hasConcept C2776912716 @default.
• W3044388571 hasConcept C2776985911 @default.
• W3044388571 hasConcept C2778609137 @default.
• W3044388571 hasConcept C502942594 @default.
• W3044388571 hasConcept C529278444 @default.
• W3044388571 hasConcept C53227056 @default.
• W3044388571 hasConcept C55493867 @default.
• W3044388571 hasConcept C62478195 @default.
• W3044388571 hasConcept C71924100 @default.
• W3044388571 hasConcept C75217442 @default.
• W3044388571 hasConcept C86554907 @default.
• W3044388571 hasConcept C86803240 @default.
• W3044388571 hasConcept C95444343 @default.
• W3044388571 hasConcept C98274493 @default.
• W3044388571 hasConceptScore W3044388571C104317684 @default.
• W3044388571 hasConceptScore W3044388571C127561419 @default.
• W3044388571 hasConceptScore W3044388571C1491633281 @default.
• W3044388571 hasConceptScore W3044388571C169760540 @default.
• W3044388571 hasConceptScore W3044388571C185592680 @default.
• W3044388571 hasConceptScore W3044388571C2776912716 @default.
• W3044388571 hasConceptScore W3044388571C2776985911 @default.
• W3044388571 hasConceptScore W3044388571C2778609137 @default.
• W3044388571 hasConceptScore W3044388571C502942594 @default.
• W3044388571 hasConceptScore W3044388571C529278444 @default.
• W3044388571 hasConceptScore W3044388571C53227056 @default.
• W3044388571 hasConceptScore W3044388571C55493867 @default.

• next